Skip to main content

HubXchange

HubXChange logo

Immunotherapies Xchange - Brussels - 2024

Page Banner 1

  1. Translational Immunology
    • Translational Immunology
    Role of combination therapies in improving immunotherapy efficacy
    New developments in the field of combination cancer therapy. Is monotherapy efficacy always essentia ...
    Nicholas Glanville
    Nicholas Glanville, Vice President of Research - Prokarium
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Evening Drinks Reception
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Spotlight Presentation
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Networking Lunch
  7. Translational Immunology
    • Translational Immunology
    Early-stage Characterization and Selection of Immuno-Oncology Drug Candidates in Customized In Vitro Assays
    Early-stage Characterization and Selection of Immuno-Oncology Drug Candidates in Customized In Vitro Assays
    From checkpoint inhibitors towards therapeutic vaccines, does one size fits it all? Fit for purpose  ...
    Christoph Schifflers
    Christoph Schifflers, Scientist Immuno-oncology - IQVIA Laboratories – In Vitro Immunology
  8. Immunogenicity
    • Immunogenicity
    Sponsor Led Roundtable Discussion
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Morning Refreshments
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
  12. Immune Regulation
    • Immune Regulation
    Avoiding recurrence of infection and minimising autoimmunity-induced side effects
    Maria Eugenia Alonso Ferrero
    Maria Eugenia Alonso Ferrero, Associate Director, Science Strategy - Alexion Pharmaceuticals
  13. Clinical Development
    • Clinical Development
    Investigating how tumour microenvironment supports immune evasion
    Mo Okily
    Mo Okily, Director, Clinical Development - Immunology - GSK
  14. Translational Immunology
    • Translational Immunology
    Application of multi-omics approaches to dissect immune responses and identify disease-associated biomarkers
    Mustafa Diken
    Mustafa Diken, Vice President Vaccines & Immunology - BioNTech SE
  15. Immunogenicity
    • Immunogenicity
    Assessing risks posed by the innate immune response
    Maria Loustau
    Maria Loustau, R&D Director - Invectys
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Opening Address & Keynote Presentation
    Opening Address & Keynote Presentation
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Registration
Search